Short interest in Spyre Therapeutics Inc (NASDAQ:SYRE) increased during the last reporting period, rising from 9.94M to 10.00M. This put 19.07% of the company's publicly available shares short.

Short interest for Spyre Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Spyre Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 554.07K shares traded per day, it would take 18.05 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.